Clincosm LogoSign in Get a demo

Ocular Hypertension

Showing NaN - NaN of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Travoprost Ophthalmic Topical Cream low-dose, Travoprost

Not yet recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Travoprost Ophthalmic Topical Cream low-dose
  • +4 more
  • Newport Beach, California
    Glaukos Clinical Study Site
Nov 22, 2023

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Glendale, Newport Beach, Cranberry Township (SBI-100 Ophthalmic

Recruiting
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • SBI-100 Ophthalmic Emulsion, 0.5%
  • +2 more
  • Glendale, California
  • +2 more
Nov 17, 2023

Glaucoma, Primary Open Angle, Ocular Hypertension Trial in Newport Beach (Study Treatment 1 WB007, Study Treatment 2 WB007,

Active, not recruiting
  • Glaucoma, Primary Open Angle
  • Ocular Hypertension
  • Study Treatment 1 WB007
  • +3 more
  • Newport Beach, California
    Eye Research Foundation
Dec 30, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (NCX 470 0.065%, NCX 470 0.1%, Latanoprost 0.005%)

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • NCX 470 0.065% (initial phase of trial)
  • +4 more
  • Newport Beach, California
    Eye Research Foundation
Oct 20, 2022

Open-angle Glaucoma, Ocular Hypertension Trial in Japan, United States (AGN-193408 SR, Lumigan, Sham Administration)

Recruiting
  • Open-angle Glaucoma
  • Ocular Hypertension
  • AGN-193408 SR
  • +3 more
  • Inglewood, California
  • +27 more
Oct 4, 2022

Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (Bimatoprost (SR))

Recruiting
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Bimatoprost (SR)
  • Sun City, Arizona
  • +112 more
Aug 16, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (Test - Bimatoprost 0.01% Ophthalmic Solution, Reference -

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Test - Bimatoprost 0.01% Ophthalmic Solution
  • Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)
  • Newport Beach, California
  • +8 more
Aug 9, 2022

Open-Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Nebivolol Ophthalmic Suspension 1 Percent, Nebivolol Ophthalmic

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Nebivolol Ophthalmic Suspension 1 Percent
  • +3 more
  • Newport Beach, California
    Site 0012
Jul 18, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (LL-BMT1)

Completed
Has Results
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • Newport Beach, California
    Eye Research Foundatoin
Jun 7, 2022

Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost SR, LUMIGAN)

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Dothan, Alabama
  • +5 more
May 17, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (NCX 470 0.1%, Latanoprost 0.005%)

Recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • NCX 470 0.1%
  • Latanoprost 0.005%
  • Newport Beach, California
    Eye Research Foundation
Apr 26, 2022

Ocular Hypertension, Open Angle Glaucoma Trial in Newport Beach (JV-GL1, Latanoprost 0.005% Ophthalmic Solution)

Active, not recruiting
  • Ocular Hypertension
  • Open Angle Glaucoma
  • JV-GL1
  • Latanoprost 0.005% Ophthalmic Solution
  • Newport Beach, California
    Eye Research Foundation
Mar 28, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Brimonidine Tartrate Ophthalmic Suspension, Brimonidine

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Brimonidine Tartrate Ophthalmic Suspension
  • Brimonidine Tartrate Ophthalmic Solution
  • Chandler, Arizona
  • +46 more
Jan 27, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (DE-126 Ophthalmic Solution 0.002% QD, Timolol Maleate

Completed
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • DE-126 Ophthalmic Solution 0.002% QD
  • Timolol Maleate Ophthalmic Solution 0.5% BID
  • Chandler, Arizona
  • +40 more
Feb 10, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham: Applicator Without Needle, Active

Completed
Has Results
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Bimatoprost SR
  • +3 more
  • Dothan, Alabama
  • +112 more
Jul 6, 2021

Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (PF-04217329, latanoprost vehicle, latanoprost)

Completed
Has Results
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Cypress, California
  • +7 more
Apr 6, 2021

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • PF-04217329 - Lowest Dose
  • +8 more
  • Artesia, California
  • +22 more
Apr 6, 2021

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Xalacom, Xalatan, Timolol)

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Birmingham, Alabama
  • +63 more
Feb 17, 2021

Ocular Hypertension, Primary Open Angle Glaucoma Trial in United States (Latanoprost ophthalmic solution, AKB-9778, Placebo)

Completed
  • Ocular Hypertension
  • Primary Open Angle Glaucoma
  • Latanoprost ophthalmic solution
  • +2 more
  • Inglewood, California
  • +20 more
Jan 13, 2021

Primary Open Angle Glaucoma, Ocular Hypertension, Pigmentary Glaucoma Trial in United States (PF-03187207 and Latanoprost

Completed
Has Results
  • Primary Open Angle Glaucoma
  • +3 more
  • PF-03187207 and Latanoprost Vehicle
  • Latanoprost 0.005% and PF-03187207 Vehicle
  • Artesia, California
  • +18 more
Sep 10, 2020

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Ocular Insert)

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +9 more
May 18, 2020

Glaucoma, Open-angle, Ocular Hypertension Trial in United States (0.01% RO7058584, 0.1% RO7058584, 1% RO7058584)

Completed
  • Glaucoma, Open-angle
  • Ocular Hypertension
  • 0.01% RO7058584
  • +4 more
  • Chandler, Arizona
  • +7 more
Mar 27, 2020

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG324 Ophthalmic Solution 0.01%, PG324 Ophthalmic Solution

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG324 Ophthalmic Solution 0.01%
  • +3 more
  • Artesia, California
  • +22 more
May 14, 2019

Glaucoma, Ocular Hypertension Trial in Newport Beach (Bimatoprost 0.03% Formulation B Ophthalmic Solution, Bimatoprost 0.03%

Completed
Has Results
  • Glaucoma
  • Ocular Hypertension
  • Bimatoprost 0.03% Formulation B Ophthalmic Solution
  • Bimatoprost 0.03% Ophthalmic Solution
  • Newport Beach, California
    (unnamed)
Apr 9, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +8 more
Mar 26, 2019